Influenza burden among chronic condition and immunocompromised patients in the United States
There remains an unmet need for additional prophylactic agents that reduce the incidence and severity of ILI among patients who are immunocompromised or have chronic conditions.
Authors
- Keith Boundy
- Prajakta Bhounsule
- Joseph Vasey
- Matt Chang
- Robert Sedgley
- Susan Mehle
Institutions
- Vir Biotechnology (Switzerland) (CH)
- VIR Biotechnology (United States) (US)
- Diagnostics for the Real World (United States) (US)
Publication Details
- Journal
- Current Medical Research and Opinion
- Published
- 2025-04-03
- DOI
- https://doi.org/10.1080/03007995.2025.2492646
- Citations
- 1
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.35